A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
27 Sep 2026 · 00:22 CST Terminal Access 终端入口 →
600329.SH上海证券交易所 · 主板 Main

Tianjin Pharmaceutical Da Ren Tang 达仁堂

Traditional Chinese Medicine 中药Ⅱ
¥35.13−¥0.26 · −0.73%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥35.47
High 最高
¥35.57
Low 最低
¥35.00
Prev Close 昨收
¥35.39
Volume 成交量
149.6万股
Turnover 成交额
¥5,276.3万
Mkt Cap 总市值
¥271亿
P/E 市盈率
31.9×
Recent Activity 近期动态All Filings 全部公告 →

3 significant filings since 30 May 2026: 1 on major holder buying, 1 on earnings pre-announcement and 1 on dividend. The latest, on 5 Aug 2026: 达仁堂关于控股股东增持公司S股股份实施结果的公告.
自 30 May 2026 起有 3 份重大公告:major holder buying 1 份、earnings pre-announcement 1 份、dividend 1 份。最新一份(5 Aug 2026):达仁堂关于控股股东增持公司S股股份实施结果的公告。

Price History 价格走势

5 sessions 个交易日, 18 Sep to 24 Sep 2026 · Live one-minute prices · High 最高 ¥35.68 · Low 最低 ¥34.05 · −0.73% on the previous close of ¥35.39
34.2534.5034.7535.0035.2535.50
18 Sep21 Sep22 Sep23 Sep24 Sep

Against Its Own History 与自身历史比较

31.9×
Median 中值 25.2× · Range 区间 7.3× to 33.5× · 20 periods 期
4.55×
Median 中值 3.76× · Range 区间 2.55× to 5.46× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥37.22¥1.1133.5×¥7.714.82×
31 Mar 2026 一季报¥40.90¥2.8314.5×¥9.774.19×
31 Dec 2025 年报¥45.62¥2.7716.5×¥9.224.95×
30 Sep 2025 三季报¥43.35¥4.669.3×¥11.703.71×
30 Jun 2025 中报¥33.36¥4.557.3×¥11.412.92×
31 Mar 2025 一季报¥30.76¥2.8910.6×¥10.672.88×
31 Dec 2024 年报¥30.80¥2.9010.6×¥10.193.02×
30 Sep 2024 三季报¥35.50¥1.2129.3×¥8.344.26×
30 Jun 2024 中报¥32.39¥1.1927.2×¥8.143.98×
31 Mar 2024 一季报¥27.90¥1.2622.1×¥9.073.08×
31 Dec 2023 年报¥33.65¥1.2826.3×¥8.573.93×
30 Sep 2023 三季报¥36.43¥1.2828.5×¥8.404.34×
30 Jun 2023 中报¥44.89¥1.4531.0×¥8.225.46×
31 Mar 2023 一季报¥40.39¥1.3829.3×¥8.934.52×
31 Dec 2022 年报¥29.10¥1.1226.0×¥8.433.45×
30 Sep 2022 三季报¥22.11¥1.0920.3×¥8.672.55×
30 Jun 2022 中报¥24.58¥1.0124.3×¥8.342.95×
31 Mar 2022 一季报¥26.63¥0.9827.2×¥8.493.14×
31 Dec 2021 年报¥31.41¥1.0031.4×¥8.233.82×
30 Sep 2021 三季报¥25.67¥1.1023.3×¥8.063.18×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥1.51¥1.51 to ¥1.51123.3×
2027¥1.55¥1.55 to ¥1.55122.7×
2028¥1.73¥1.73 to ¥1.73120.3×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA